Sarah Cannon Research Institute
Chandra King has a diverse work experience spanning several companies. Chandra started their career as a Nurse Extern at Vanderbilt University Medical Center in 2002 and worked in that role until 2006. Chandra then joined HCA in 2006 as a Certified Nursing Assistant before transitioning to the role of Accounts Payable Specialist in 2007. In the same year, Chandra moved to Sarah Cannon Research Institute and initially worked as a Budget and Contract Analyst. Chandra gradually advanced through various managerial positions, including Manager, Budgets and Contracts from 2008 to 2015, Manager, Late Phase Data Support Operations from 2015 to 2017, and Senior Manager, Late Phase Data Operations from 2017 to 2019. Chandra'smost recent role at Sarah Cannon Research Institute was Director of Site Support Operations from 2019 to 2023, after which they became the Assistant Vice President of Site Support Operations.
Chandra King attended Tennessee State University where they studied nursing. Chandra also pursued an Associate of Science degree at Volunteer State Community College, but no specific field of study is mentioned.
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.